AstraZeneca India gets dual CDSCO approval for Trastuzumab deruxtecan
Additional indications for treatment of HER2 low breast cancer and HER2 positive gastric / gastro-oesophageal cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Sanofi signs distribution pact with Cipla for CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium
Merck Life Science signs MoU with Amity University, UP, Noida Campus for academic and research…
Under this MoU, 'practical and industry oriented certificate courses' focusing on advanced instrumentation will be offered to the…
Pharmazz, Dr Reddy’s enter licensing pact to market Centhaquine in India
Centhaquine is a resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase…
Vaccines in late-stage development hold promise in tackling disease burden: GlobalData
According to GlobalData, there are 11 vaccines in late-stage development* for TB globally
vriddhi 2024: The Indian pharma industry comes together to deliberate on glorious future
Mehul Shah, Honorary General Secretary, Indian Drug Manufacturers' Association (IDMA) and Managing Director of Encube Ethicals…
Pfizer’s Braftovi to command 42 per cent share of BRAF inhibitors melanoma market by 2028:…
GlobalData’s patient-based forecast reveals that the BRAF inhibitor market for melanoma will reach a key milestone by 2028, with…
STEERWorld announces its Strategic Advisory Board
Naiyya Saggi, Vipul Parekh and Sachin Oswal will bring diverse perspectives and strategic guidance as Steer enters its next phase…
Dr Reddy’s launches Versavo (bevacizumab) in the UK
It is indicated for the treatment of several types of cancers
DP World expands its global freight forwarding network
Including 16 plus locations in India in major metros and tier I cities
Sun Pharma gets approval for Winlevi in Australia
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Healthcare industry reported 97 deals worth $38.1 billion in Feb 2024
Deal value increased by 977 per cent in February 2024, compared to February 2023
Sustainable pharmaceuticals: Addressing environmental concerns
Dr Amit Pandit, School of Pharmacy & Technology Management, NMIMS, Indore & Shirpur Campuses, explores the imperative for…
GLP1 agonists set to become the best-selling drugs in 2024: GlobalData
Shift could reflect a changing demand away from oncology toward addressing metabolic disorders
Sanofi India, Emcure Pharma announce exclusive distribution partnership
Emcure to distribute and promote Sanofi’s cardiovascular brands in India
Zydus launches IBYRA, the generic version of Olaparib
The drug will target specific genetic mutations prevalent in certain types of cancers
Biotech funding set for recovery in 2024: GlobalData
This optimism follows a downturn in private biotech venture financing, where funding in 2023 declined by 43.2 per cent and 52.3…
DOP amends PTUAS, expands eligibility criteria to include MSMEs
Offers flexible financing options, and focuses on reimbursement subsidies from 10-20 per cent to MSMEs
Emcure Pharma forays into OTC market with Galact supplement for breastfeeding mothers
Enriched with the potency of Shatavari and six other herbs, Galact is meticulously formulated to boost breast milk production for…
Venus Remedies gets UNICEF GMP approval
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry…